TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
167
|
134
|
114 |
| Financial expenses |
2
|
1
|
2 |
| Earnings before taxes |
-163
|
-305
|
-270 |
| EBITDA |
-155
|
-299
|
-262 |
| Total assets |
110
|
161
|
149 |
| Current assets |
97
|
145
|
126 |
| Current liabilities |
40
|
73
|
24 |
| Equity capital |
26
|
53
|
48 |
| - share capital |
6
|
6
|
6 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
23.6%
|
32.9%
|
32.2% |
| Turnover per employee |
42
|
34
|
38 |
| Profit as a percentage of turnover |
-97.6%
|
-227.6%
|
-236.8% |
| Return on assets (ROA) |
-146.4%
|
-188.8%
|
-179.9% |
| Current ratio |
242.5%
|
198.6%
|
525.0% |
| Return on equity (ROE) |
-626.9%
|
-575.5%
|
-562.5% |
| Change turnover |
33
|
29
|
59 |
| Change turnover % |
24%
|
28%
|
109% |
| Chg. No. of employees |
0
|
1
|
2 |
| Chg. No. of employees % |
0%
|
33%
|
200% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.